Details of Disease

General Information of Disease (ID: DIS47W6X)

• Disease Name: Molluscum contagiosum infection
• Disease Class: 1E76: Molluscum contagiosum
• Disease Hierarchy:
  DIS01GPL: Grass pollen hypersensitivity
  DIS47W6X: Molluscum contagiosum infection
• ICD Code:
  ICD-11: ICD-11: 1E76
  ICD-10: ICD-10: B08.1

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 1 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Cantharidin	DMBP5N3	Approved	Small molecular drug	[1]

This Disease is Treated as An Indication in 4 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
SB206	DMMF3HI	Phase 3	NA	[2]
VP-102	DM5T4IS	Phase 3	NA	[3]
Nanoemulsion	DMDJ5IT	Phase 2/3	NA	[4]
VBP-245	DM97Q8Y	Phase 2	NA	[5]

Molecular Interaction Atlas (MIA) of This Disease

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
• [2] ClinicalTrials.gov (NCT03927716) A Phase 3 Randomized Parallel Group Study Comparing the Efficacy & Safety of SB206 & Vehicle Gel in the Treatment of MC (B-SIMPLE1). U.S. National Institutes of Health.
• [3] ClinicalTrials.gov (NCT03377803) Cantharidin Application in Molluscum Patients (CAMP-2). U.S. National Institutes of Health.
• [4] ClinicalTrials.gov (NCT01326078) Use of Lipid Emulsion or Nanoemulsion of Propofol on Children Undergoing Ambulatory Invasive Procedures.. U.S. National Institutes of Health.
• [5] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)